352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arcosa signed Amendment No. 1 to its credit agreement on August 15, 2024, to permit and help finance its $1.2 billion cash acquisition of Stavola's construction materials business. The amendment adds a $700.0 million Term Loan B, increases the revolving credit facility from $600.0 million to $700.0 million, and adds substantially all of the company's personal property as collateral; the Term Loan and collateral terms take effect only when conditions, including the closing of the acquisition, are met.
Credit agreement amendment dated August 15, 2024, with JPMorgan Chase Bank, N.A. as administrative agent
Term Loan of up to $700.0 million at SOFR plus 2.25%, due on the seventh anniversary of initial funding
Revolving credit facility increased from $600.0 million to $700.0 million; maximum leverage ratio set at 5.00 to 1.00 in the quarter the transaction closes
Acquisition is financed with the Term Loan plus $600.0 million of 6.875% senior unsecured notes due 2032
Quest Diagnostics issued $1.85 billion of senior notes in three tranches due 2027, 2029 and 2034, with the offering priced on August 15, 2024 and closing on August 19, 2024. The company said it intends to use the proceeds mainly to fund the purchase price of its previously announced LifeLabs acquisition, which adds debt tied to that deal.
$400 million of 4.600% senior notes due December 15, 2027, $600 million of 4.625% notes due 2029, and $850 million of 5.000% notes due 2034
If the LifeLabs acquisition is not completed by the Termination Date, the 2027 and 2029 notes must be redeemed at 101% of principal plus accrued interest; the 2034 notes remain outstanding
Interest is paid June 15 and December 15 each year, beginning December 15, 2024
UDR, Inc. entered into a second amendment to its credit agreement on August 14, 2024, extending its $1.3 billion senior unsecured revolving credit facility and adding an extension option to its $350 million term loan. The amended agreement allows total commitments and borrowings to be increased to up to $2.5 billion, subject to conditions, which gives the company expanded borrowing capacity.
Revolving Credit Facility matures August 31, 2028, with two six-month extension options
Term Loan matures January 31, 2027, with one twelve-month extension option
Accordion feature allows up to $2.5 billion in aggregate commitments and borrowings, subject to lender commitments
Based on current credit rating, revolver margin is 77.5 basis points and facility fee is 15 basis points
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.